Organon (OGN) Income from Continuing Operations (2020 - 2026)
Organon's Income from Continuing Operations came in at $108 million for Q2 2026, down 25.5% from $145 million a year earlier and down 26.0% from the prior quarter.
Powered by 
Analysis
Organon (OGN) Income from Continuing Operations (2020 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Organon reported Income from Continuing Operations of $209 million, down 70.1% year-over-year; for FY2025, it was $187 million, down 78.4% from FY2024.
- Income from Continuing Operations carries a five-year compound annual growth rate of -39.2% (FY2020 to FY2025).
- Going back by year, Income from Continuing Operations was $864 million in FY2024 (-15.5%), $1.02 billion in FY2023 (+11.6%), $917 million in FY2022 (-32.1%) and $1.35 billion in FY2021 (-40.1%).
- The five-year range for quarterly Income from Continuing Operations is -$205 million (Q4 2025) to $546 million (Q4 2023).
- Year-over-year, Income from Continuing Operations increased in two of the last seven quarters, with growth averaging 49.1%.
- The fastest year-over-year change in Income from Continuing Operations over five years came in Q3 2024 (growth of 519.0%), and the weakest in Q4 2024 (a decline of 80.0%).
- Business Quant data shows OGN's Income from Continuing Operations at $146 million (Q1 2026), -$205 million (Q4 2025) and $160 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.28 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 3.09 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -246.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Organon | 3.60 Bn | 106.37 Mn | 847.00 Mn | 108.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 108.00 Mn |
| Mar 31, 2026 | 146.00 Mn |
| Dec 31, 2025 | -205.00 Mn |
| Sep 30, 2025 | 160.00 Mn |
| Jun 30, 2025 | 145.00 Mn |
| Mar 31, 2025 | 87.00 Mn |
| Dec 31, 2024 | 109.00 Mn |
| Sep 30, 2024 | 359.00 Mn |
| Jun 30, 2024 | 195.00 Mn |
| Mar 31, 2024 | 201.00 Mn |
| Dec 31, 2023 | 546.00 Mn |
| Sep 30, 2023 | 58.00 Mn |
| Jun 30, 2023 | 242.00 Mn |
| Mar 31, 2023 | 177.00 Mn |
| Dec 31, 2022 | 108.00 Mn |
| Sep 30, 2022 | 227.00 Mn |
| Jun 30, 2022 | 234.00 Mn |
| Mar 31, 2022 | 348.00 Mn |
| Dec 31, 2021 | 202.00 Mn |
| Sep 30, 2021 | 323.00 Mn |
API Access
Organon Income from Continuing Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=OGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-continuing-operations", "ticker": "OGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=OGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();